Pricing Log in Create free account

Fractyl Health, Inc. (GUTS) vs Psyence Biomedical Ltd. (PBM)

Fractyl Health, Inc. and Psyence Biomedical Ltd. are both Biotechnology companies. Fractyl Health, Inc. and Psyence Biomedical Ltd. are of similar size ($11.9M and $11.2M). Fractyl Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.1×. Across the 9 metrics below, Fractyl Health, Inc. leads on 6 and Psyence Biomedical Ltd. on 3.

Valuation

Metric GUTS PBM Biotechnology median
P/E n/m 0.13 10.26
P/S 127.89 n/m 9.18
P/B n/m 0.06 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.06 1.91 0.65
EV/Sales (51.61) n/m 8.98
Earnings yield (1,173.80%) 759.84% (34.89%)
Free cash flow yield (697.71%) (1,147.64%) (24.52%)

Profitability

Metric GUTS PBM Biotechnology median
Gross margin 46.24% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 1,063.04% (23.52%) (50.12%)
Return on assets (146.75%) (6.74%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GUTS PBM Biotechnology median
Revenue growth (TTM) (22.50%) — 6.26%
EPS growth (last fiscal year) (14.81%) (138.35%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GUTS PBM Biotechnology median
Debt to equity (18.29) 0.00 0.00
Current ratio 3.15 8.09 4.89
Net debt to EBITDA 0.53 1.20 1.01

Dividend

Metric GUTS PBM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GUTS PBM Biotechnology median
Market cap 11.88m 11.21m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack